null

Biotinylated Anti-CD19 (Inebilizumab biosimilar)mAb (HDBS0261)

SKU:
HDBS0261
Antibody Type:
Biotinylated Biosimilar
Modifications:
Biotinylated
Applications:
SPR
ELISA
Drug Development
Pharmacokinetics
Disease Area:
B-Cell Malignancies
Disease Area:
Immunotherapy
Size:
100 μg
Target:
CD19
Isotype:
IgG1
Host Species:
Humanized
Reactivity:
Human
$515

Description

system_update_altDatasheetsystem_update_altMSDS